Conference on Biowaivers and Biosimilars 2014

Keywords: biowaivers, biowaivers conference, biosimilars, biosimilars conference
Published on June 10, 2014
OMICS Group contributes to the scientific community through its Open Access Initiative and OMICS Group Conferences. OMICS Group hosts over 350 leading-edge peer reviewed Open Access Journals which are supported by more than 30000 eminent Editorial Board Members through a 21 Days rapid, quality and quick review process. OMICS Group Conferences invites all the participants across the globe to attend the 3rd International Conference and Exhibition on Biowaivers and Biosimilars during October 27-29, 2014 Hyderabad, India. The main theme of the conference is Current Challenges and Opportunities in Cost Effective and Affordable Biosimilars which covers a wide range of critically important sessions. Biosimilars 2014 is the best platform for Pharma, CMOs, CROs, research institutes, investors and industry stakeholders to meet, associate and discuss current industry trends and establish business partnerships. The target audience will be Vice Presidents, Directors, Heads of Departments in the field of Intellectual Property, Business Development, Bioequivalence, Regulatory/Legal Affairs, Research and Development and pharmacovigilance. Biosimilars 2014 will gather the experts in the biosimilar development, manufacturing and commercialization decision makers from all over the world. Biosimilars-2014 is collaborated with DPA (Doctor of Pharmacy Association) and PAAi (Patent Agent Association). Workshop is being organized by Dr. Shivraj Dasari, CSO of SLS Cell Culture Technologies Pvt. Ltd at this esteemed scientific conference and this event will boost your industry knowledge and enhance relationships by networking between industrialists and academic leaders.
Category: Pharmaceutical Sciences
No comments.